Latest Articles

Publication Date
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment.

Endometriosis is a common gynecological condition that usually affects women during their reproductive years. The main goal of this narrative review is to understand the role of the innate and …

Published: July 1, 2025, midnight
Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC - CancerNetwork

Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC CancerNetwork

Published: June 17, 2025, 6:09 p.m.
More evidence links physical activity with improved cancer survival - MSN

More evidence links physical activity with improved cancer survival MSN

Published: May 28, 2025, 12:20 a.m.
More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds - American Cancer Society Press Room

More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds American Cancer Society Press Room

Published: May 21, 2025, 3:01 p.m.
More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds | Newswise - Newswise

More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds | Newswise Newswise

Published: May 20, 2025, 11:30 p.m.
and poor overall patient survival in - ResearchGate

and poor overall patient survival in ResearchGate

Published: May 11, 2025, 2:51 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature

DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature

Published: May 10, 2025, 10:19 a.m.
Uterine Cancer Survival Varies Widely by Race Across US - Medscape

Uterine Cancer Survival Varies Widely by Race Across US Medscape

Published: May 7, 2025, 12:27 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!